Abstract
The discovery of the delicate role of endogenous nitric oxide in the homeostasis of various cellular functions and the dynamic behaviour of the airways, has led to a new, rapidly progressing area of physiological science, that has direct bearing for our understanding of multiple airway diseases. The potentially protective effects of nitric oxide include: neuromodulation by mediating inhibitory non-cholinergic nonadrenergic nerve activity; smooth muscle relaxation, attenuating airway hyperresponsiveness to bronchoconstrictor stimuli and immun-suppression. NO itself or SNO can be administerd directly to the airways, and the development of gene transfer therapy seems to become a realistic approach in the treatment of airway diseases. However, NO has also harmfull effects, especially when it interacts with other molecules. At present, there are novel opportunities to modulate nitric oxidesynthesis aimed to restore the balance between the protective and deleterious effects of nitric oxide. This is potentially beneficial in both airway and alveolar diseases. Such interventions might be targeted in various ways, e.g. by using selective reactive nitrogen- and oxygen- scavengers, selective NO donors and selective nitric oxide synthase inhibitors. The possible therapeutical opportunities are reviewed in this paper. Nitric oxide has already made it from the bench to the bedside, and it is likely that new developments in this area will drastically change respiratory medicine during the coming 5- 10 years.
Keywords: Asthma, Allergie, Airway hyperresponsivenes, Nitric oxide synthase, Therapy, Reactive oxygen species, Thiols, Arginase
Current Pharmaceutical Design
Title: Nitric Oxide in Asthma Therapy
Volume: 12 Issue: 25
Author(s): Gert Folkerts and Frans P. Nijkamp
Affiliation:
Keywords: Asthma, Allergie, Airway hyperresponsivenes, Nitric oxide synthase, Therapy, Reactive oxygen species, Thiols, Arginase
Abstract: The discovery of the delicate role of endogenous nitric oxide in the homeostasis of various cellular functions and the dynamic behaviour of the airways, has led to a new, rapidly progressing area of physiological science, that has direct bearing for our understanding of multiple airway diseases. The potentially protective effects of nitric oxide include: neuromodulation by mediating inhibitory non-cholinergic nonadrenergic nerve activity; smooth muscle relaxation, attenuating airway hyperresponsiveness to bronchoconstrictor stimuli and immun-suppression. NO itself or SNO can be administerd directly to the airways, and the development of gene transfer therapy seems to become a realistic approach in the treatment of airway diseases. However, NO has also harmfull effects, especially when it interacts with other molecules. At present, there are novel opportunities to modulate nitric oxidesynthesis aimed to restore the balance between the protective and deleterious effects of nitric oxide. This is potentially beneficial in both airway and alveolar diseases. Such interventions might be targeted in various ways, e.g. by using selective reactive nitrogen- and oxygen- scavengers, selective NO donors and selective nitric oxide synthase inhibitors. The possible therapeutical opportunities are reviewed in this paper. Nitric oxide has already made it from the bench to the bedside, and it is likely that new developments in this area will drastically change respiratory medicine during the coming 5- 10 years.
Export Options
About this article
Cite this article as:
Folkerts Gert and Nijkamp P. Frans, Nitric Oxide in Asthma Therapy, Current Pharmaceutical Design 2006; 12 (25) . https://dx.doi.org/10.2174/138161206778194141
DOI https://dx.doi.org/10.2174/138161206778194141 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Traditional Uses, Phytochemistry, and Pharmacological Activities of <i>Coleus
amboinicus</i>: A Comprehensive Review
Current Pharmaceutical Design Linseed Essential Oil – Source of Lipids as Active Ingredients for Pharmaceuticals and Nutraceuticals
Current Medicinal Chemistry Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Dendritic Cells in Pathogenesis of COPD
Current Pharmaceutical Design A Stress Repair Mechanism That Maintains Vertebrate Structure During Stress
Cardiovascular & Hematological Disorders-Drug Targets Beta-Blockers: Current State of Knowledge and Perspectives
Mini-Reviews in Medicinal Chemistry B-Cell Based Gene Therapy for Autoimmune Diseases
Infectious Disorders - Drug Targets Preclinical Models of Graves’ Disease and Associated Secondary Complications
Current Pharmaceutical Design Role of P-gp and HDAC2 and their Reciprocal Relationship in Uncontrolled Asthma
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Cold Virus Fusion or Stopping Fusion Cold – Inhibitors of the Human Respiratory Syncytial Virus F Protein
Recent Patents on Anti-Infective Drug Discovery Asthma-COPD Overlap: A more Simplistic Approach
Current Respiratory Medicine Reviews Recent Developments in the Medicinal Chemistry of NK2 Receptor Antagonists
Current Topics in Medicinal Chemistry Pediatric Chronic Daily Headache
Current Pediatric Reviews Preface:
Drug Metabolism Letters Complications and Outcome of H1N1 Influenza in a Tertiary Care Hospital in South India A Retrospective Study
Current Respiratory Medicine Reviews The Effectiveness of Interventions to Address Health Inequalities During Pregnancy: A Review of Relevant Literature
Current Women`s Health Reviews Biomarkers in Asthma - Interpretation, and Utility in Current Asthma Management
Current Respiratory Medicine Reviews Biodegradable Hydrogel Bead of Casein and Modified Xanthan Gum for Controlled Delivery of Theophylline
Current Drug Therapy Advances of Knowledge on Allergic Inflammation and the Oral Mucosa
Recent Patents on Inflammation & Allergy Drug Discovery